cfDNA Increased in Patients With Pulmonary Arterial Hypertension
Transplant-free survival predicted by cfDNA levels stratified into tertiles, REVEAL risk groups; discrimination increased with adding cfDNA to REVEAL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.